DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
Joaquı́n Mateo(Royal Marsden NHS Foundation Trust), Johann S. de Bono(Royal Marsden NHS Foundation Trust), Emma Hall(Institute of Cancer Research), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust), Wei Yuan(Shanghai Public Health Clinical Center), Gunther Boysen, Roberta Ferraldeschi(Royal Marsden NHS Foundation Trust), Raquel Pérez-López(Vall d'Hebron Institut de Recerca), Rachel Brough(Institute of Cancer Research), Felix Y. Feng(University of Michigan), Ursula McGovern(University College Hospital), Syed A. Hussain(University Hospitals Plymouth NHS Trust), Xuhong Cao(Howard Hughes Medical Institute), Mark A. Rubin(University of Bern), Chris T. Williamson(Institute of Cancer Research), Roger A’Hern, Bernardette Ebbs, Aurelius Omlin(University of Zurich), Helen Mossop, Karen E. Knudsen(American Cancer Society), Helen N. Pemberton(Institute of Cancer Research), Robert J. Jones(Beatson West of Scotland Cancer Centre), Claire Paulding, Amanda Swain(Institute of Cancer Research), Nina Tunariu(Leicester Royal Infirmary), Alan Ashworth(University of California, San Francisco), Gemma Fowler, Andrew Protheroe(University of Oxford), Susana Miranda(Royal Marsden NHS Foundation Trust), Shahneen Sandhu(The University of Melbourne), Ruth Riisnaes(Institute of Cancer Research), Penny Flohr(Royal Marsden NHS Foundation Trust), Christy Ralph(University of Leeds), Desamparados Roda(Institute of Cancer Research), Núria Porta, Tony Elliott(The Christie Hospital), Dan R. Robinson(University of Michigan), Daniel Nava Rodrigues(Institute of Cancer Research), Zafeiris Zafeiriou(Royal Marsden NHS Foundation Trust), Alexa Gillman, Suzanne Carreira(Institute of Cancer Research), Christopher J. Lord(Institute of Cancer Research), Diletta Bianchini(Royal Marsden NHS Foundation Trust), Yi‐Mi Wu, Ines Figueiredo(Institute of Cancer Research), Arul M. Chinnaiyan(Howard Hughes Medical Institute), Lakshmi P. Kunju(University of Michigan), Gerhardt Attard(London Cancer), Suneil Jain(Queen's University Belfast), George Seed(Institute of Cancer Research), Jane Goodall
Cited by 2,185
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k